Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, MA, will become the majority of Novo Nordisk’s U.S.-based R&D activities.     Novo Nordisk anticipates adding more than 200 new jobs in the Boston area in 2023. Of these new positions, more than 150 will be lab-based and clinical development personnel...